Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?

Jürg Bernhard, B. Thürlimann, S. F. Hsu Schmitz, M. Castiglione-Gertsch, F. Cavalli, R. Morant, M. F. Fey, H. Bonnefoi, A. Goldhirsch, C. Hürny

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?'. Together they form a unique fingerprint.

Medicine & Life Sciences